DC

Dr Christoph Paul Josef Willers

Active Director Director DIN 10489461
DIN 10489461 First appointment Feb 2024 Primary industry Paper
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Feb 2024
Shareholding value β€’β€’β€’β€’ Premium profile

About Dr Christoph Paul Josef Willers

Data last updated:

Dr Christoph Paul Josef Willers is a Director at Allergopharma India Private Limited (since 2024). The company operates in Paper.

DIN 10489461
Primary Designation Director
Industry Paper
First Appointment 02 Feb 2024
Oldest Company Age 2 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Allergopharma India Private Limited U21002DL2024FTC426111
Director02 Feb 20242024Active

Board colleagues of Dr Christoph Paul Josef Willers

NameDINCompanyDesignation
Vivek Narang10489460Allergopharma India Private LimitedNon- Individual Subscriber

Directorship timeline

Open interactive timeline →
Allergopharma India Private Limited
Premium access

Shareholding and investment profile for Dr Christoph Paul Josef Willers

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Dr Christoph Paul Josef Willers

Dr Christoph Paul Josef Willers currently holds 1 directorship: Allergopharma India Private Limited (Director, since 02 Feb 2024).

Dr Christoph Paul Josef Willers was first appointed on 02 Feb 2024 as Director at Allergopharma India Private Limited.

The current boards of Dr Christoph Paul Josef Willers's companies include Vivek Narang (Allergopharma India Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available